• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Cornell Helen W

    4/2/25 4:12:49 PM ET
    $HI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $HI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    CORNELL HELEN W

    (Last) (First) (Middle)
    ONE BATESVILLE BOULEVARD

    (Street)
    BATESVILLE IN 47006

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Hillenbrand, Inc. [ HI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    03/31/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 11,691 I By Helen W. Cornell 2020 Irrevocable Trust
    Common Stock 1,500 I By Helen W. Cornell Rev. Trust
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (Deferred Stock Award 2/22/12) (1) 03/31/2025 A(2) 59 (3) (3) Common Stock 59 $0 6,458 D
    Restricted Stock Units (Deferred Stock Award 2/27/13) (1) 03/31/2025 A(2) 47 (3) (3) Common Stock 47 $0 5,194 D
    Restricted Stock Units (Deferred Stock Award 2/26/14) (1) 03/31/2025 A(2) 36 (3) (3) Common Stock 36 $0 4,098 D
    Restricted Stock Units (Deferred Stock Award 2/25/15) (1) 03/31/2025 A(2) 37 (3) (3) Common Stock 37 $0 4,048 D
    Restricted Stock Units (Deferred Stock Award 2/24/16) (1) 03/31/2025 A(2) 42 (3) (3) Common Stock 42 $0 4,607 D
    Restricted Stock Units (Deferred Stock Award 2/22/17) (1) 03/31/2025 A(2) 30 (3) (3) Common Stock 30 $0 3,256 D
    Restricted Stock Units (Deferred Stock Award 2/15/18) (1) 03/31/2025 A(2) 26 (3) (3) Common Stock 26 $0 2,877 D
    Restricted Stock Units (Deferred Stock Award 2/14/19) (1) 03/31/2025 A(2) 26 (3) (3) Common Stock 26 $0 2,886 D
    Restricted Stock Units (Deferred Stock Award 2/13/20) (1) 03/31/2025 A(2) 39 (3) (3) Common Stock 39 $0 4,316 D
    Restricted Stock Units (Deferred Stock Award 2/11/21) (1) 03/31/2025 A(2) 28 (4) (4) Common Stock 28 $0 3,040 D
    Restricted Stock Units (Deferred Stock Award 2/10/22) (1) 03/31/2025 A(2) 25 (4) (4) Common Stock 25 $0 2,808 D
    Restricted Stock Units (Deferred Stock Award 2/24/23) (1) 03/31/2025 A(2) 39 (4) (4) Common Stock 39 $0 4,259 D
    Restricted Stock Units (Deferred Stock Award 2/20/24) (1) 03/31/2025 A(2) 46 (4) (4) Common Stock 46 $0 4,991 D
    Restricted Stock Units (Deferred Stock Award 2/18/25) (1) 03/31/2025 A(2) 61 (4) (4) Common Stock 61 $0 6,642 D
    Explanation of Responses:
    1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.
    2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.
    3. These Restricted Stock Units vest immediately upon grant. However, for awards granted prior to May 2014, directors must hold the underlying shares of common stock of the Company for six months after they cease serving as a director, and for awards granted in May 2014 or later, directors must hold the underlying shares of common stock of the Company for one day after the director ceases serving.
    4. These Restricted Stock Units vest on the earlier to occur of the issuer's next annual meeting of shareholders or one year from the date of grant; provided, that these Restricted Stock Units will immediately vest upon, and in any case delivery of the shares underlying these Restricted Stock Units will not occur until, the occurrence of one of the following: a change in control of the issuer, the director's death or permanent and total disability, or one day after the date the director ceases to be a director of the issuer.
    Remarks:
    /s/ Veronica L. McCarthy, Attorney-in-fact for Helen W. Cornell 04/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HI

    DatePrice TargetRatingAnalyst
    5/8/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    8/12/2024$54.00 → $33.00Buy → Neutral
    DA Davidson
    7/10/2024$50.00Overweight
    KeyBanc Capital Markets
    12/19/2023$61.00Strong Buy
    CL King
    More analyst ratings